The elderly people, fragile, suffering of diabetes, severe venous insufficiency, and after chemotherapy, often suffer of non-healing wounds. Besides, the major burns, furuncles, and abscesses stubbornly resist treatment. The most dangerous of them are surgical or burn wounds infected with hospital microbial strains – Staphylococcus aureus, Pseudomonas Aureginosa, etc., resistant to the majority of antibiotics used in modern clinical practice.
The bacteria from the wound can penetrate the blood channels inducing severe systemic infections (endocarditis, sepsis, etc.). The following symptoms may speak for development of systemic infections: general uneasiness, body temperature rise, shivers, occurring during a week after the wound onset.
Bacteriophages, in particular Pyofag®, are used for the prevention and treatment of pyogenic and septic complications of wound processes. The product exerts bactericidal effect on a series of common pathogens, including those resistant to antibiotics.
For treatment of pyogenic wounds, burns, abscesses, as well as for prevention of pyogenic and septic infections of soft tissue Pyofag® product is applied locally as well as orally.
The product is applied in the form of irrigations, soaking therapy, and applications (gauze wipe soaked in bacteriophage is applied on the area of inflammation 2 times a day), as well as rinsing and drainages not less than 1 time a day in the dose of 20 to 40 ml during 10 days. In the case of abscesses bacteriophage is inserted in the wound cavity after evacuation of purulence using puncturing. The product is applied orally according to the age dose 3 times a day 1 hour before meals during 7-20 days.
Р.С. № UA/15974/01/01. Approved by the Order of the Ministry of Public Health of Ukraine No. 478 of 28.04.2017.
The information on the product is presented for information purposes only and shall not be used as a guide for self-treatment. Only a doctor can make a decision as to prescribing of the product, as well as doses thereof and method of administration.